Buprenorphine And Naloxone Tablet
Product Images NDC 60687-637

9 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 60687-637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp62665

Ahp62665
Two sublingual tablets of Buprenorphine and Naloxone shown. The top tablet is larger, oval-shaped, with the imprint 'PP'. The bottom tablet is smaller, round, and imprinted with '02'. Both tablets are white or off-white in color.*
FDA Label Image

Ahp63765

Ahp63765
Image of round, white sublingual tablets marked with embossed letters "RP" on one side and "n8" on the other. The tablets correspond to Buprenorphine and Naloxone, a human prescription drug tablet by American Health Packaging.*
FDA Label Image

Buprenorphine Structural Formula (Buprenorphine Structure)

Buprenorphine Structural Formula (Buprenorphine Structure)
Chemical structure of Buprenorphine and Naloxone showing the molecular framework typical for Buprenorphine with a hydrochloride (HCl) designation. The diagram presents key functional groups and stereochemistry of the molecule.*
FDA Label Image

Naloxone Structural Formula (Naloxone Structure)

Naloxone Structural Formula (Naloxone Structure)
Chemical structure of Buprenorphine hydrochloride dihydrate, showing its molecular framework with rings and functional groups.*
FDA Label Image

Image Of Tablet Placement (Instructions)

Image Of Tablet Placement (Instructions)
An instructional illustration showing a person lifting their upper lip to place a sublingual tablet inside the mouth, near the gum line, demonstrating proper placement for buprenorphine and naloxone sublingual tablet administration.*
FDA Label Image

2 mg 0.5 mg Buprenorphine Naloxone Tablets Carton.jpg (2 mg 0.5 mg Buprenorphine Naloxone Tablets Carton.jpg)

2 mg 0.5 mg Buprenorphine Naloxone Tablets Carton.jpg (2 mg 0.5 mg Buprenorphine Naloxone Tablets Carton.jpg)
Label for Buprenorphine and Naloxone sublingual tablets, USP, 2 mg/0.5 mg strength, containing 50 tablets (5 strips of 10). The label includes the NDC 60687-626-65, indicates Rx only, and is distributed by American Health Packaging. It also features a medication guide warning and usage instructions for pharmacists.*
FDA Label Image

2 mg 0.5 mg Buprenorphine Naloxone Tablet Blister.jpg (2 mg 0.5 mg Buprenorphine Naloxone Tablet Blister.jpg)

2 mg 0.5 mg Buprenorphine Naloxone Tablet Blister.jpg (2 mg 0.5 mg Buprenorphine Naloxone Tablet Blister.jpg)
Multiple identical labels for Buprenorphine and Naloxone Sublingual Tablet, USP 2 mg/0.5 mg, arranged in a grid pattern. Each label includes the product name, strength, dosage form, NDC barcode, expiration and lot number placeholders, and American Health Packaging as the labeler in Columbus, Ohio.*
FDA Label Image

8 mg 2 mg Buprenorphine Naloxone Tablets Carton.jpg (8 mg 2 mg Buprenorphine Naloxone Tablets Carton)

8 mg 2 mg Buprenorphine Naloxone Tablets Carton.jpg (8 mg 2 mg Buprenorphine Naloxone Tablets Carton)
Label for Buprenorphine and Naloxone Sublingual Tablets, USP, 8 mg/2 mg strength. The label shows packaging for 50 tablets (5 blister cards of 10 tablets each) with a Schedule III controlled substance symbol. Distributed by American Health Packaging, Columbus, Ohio. Includes barcode, usage warnings, and instructions for pharmacists to dispense a medication guide with each patient.*
FDA Label Image

8 mg 2 mg Buprenorphine Naloxone Tablet Blister.jpg (8 mg 2 mg Buprenorphine Naloxone Tablet Blister)

8 mg 2 mg Buprenorphine Naloxone Tablet Blister.jpg (8 mg 2 mg Buprenorphine Naloxone Tablet Blister)
Multiple identical packaging labels for Buprenorphine and Naloxone Sublingual Tablet, USP 8 mg/2 mg. Each label includes the product name, strength, dosage form, and labeler American Health Packaging. The labels also show a barcode, lot number, and expiration date placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.